LB PHARMACEUTICALS INC (LBRX) Free cash flow 2024–2025
LB PHARMACEUTICALS INC (LBRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$35.3MFY2025 · since FY2024: -$53.8M → -$35.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$35.3M | +34.5% |
| FY2024 | -$53.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LBRX financial trends
LBRX RevenueLBRX Net incomeLBRX Net marginLBRX Gross profitLBRX Gross marginLBRX Operating incomeLBRX Operating marginLBRX Operating cash flowLBRX Capital expendituresLBRX Return on equityLBRX Stock buybacksLBRX Dividends paidLBRX Total assetsLBRX Total liabilitiesLBRX Shareholders’ equityLBRX overview →